Ursomore-300 Tablets provide an established, clinically unified hepatobiliary therapy carefully developed for the dissolution of radiolucent cholesterol gallstones and the systematic management of chronic cholestatic liver diseases like Primary Biliary Cholangitis (PBC). By modifying the overall composition and circulation balance of the body’s internal bile acid pool, this formulation decreases metabolic liver stress, safeguards cell membrane architectures, and optimizes daily biliary flow.
The active component, Ursodeoxycholic Acid (300 mg), is a naturally occurring hydrophilic, non-toxic bile acid. It functions primarily by suppressing the synthesis and secretion of cholesterol from the liver, while simultaneously reducing its relative absorption in the intestinal tract. This dual action dramatically lowers the cholesterol saturation index of bile, allowing cholesterol precipitates trapped inside the gallbladder to gradually dissolve over extended treatment timelines. Additionally, in chronic liver diseases, Ursomore-300 works via a cytoprotective mechanical layout; it competitively replaces toxic, hydrophobic endogenous bile acids that otherwise damage hepatocytes. By stimulating bicarbonate-rich biliary secretion and decreasing cellular immunological stress tracking, it limits progressive bile duct injury and stabilizes long-term hepatic parameters.
Key Benefits
-
Non-Surgical Gallstone Care: Helps slowly break down and dissolve clear cholesterol gallstones, keeping the gallbladder clear.
-
Hepatoprotective Armor: Displaces toxic bile acids to shield hepatic cell walls from oxidative damage and inflammation.
-
Improves Bile Fluidity: Enhances the natural secretion and outflow of bile, preventing painful stagnation and sludge formation.
-
Supports Metabolic Liver Profiles: Helps improve long-term serum liver enzyme levels (like ALT, AST, and GGT) in cholestatic conditions.
-
Trusted Quality: Manufactured under the strict quality benchmarks of Dr. Morepen, ensuring exact dosing uniformity and premium active ingredient integration.
Directions for Use
-
Take exactly as directed by your gastroenterologist, hepatologist, or primary physician.
-
Swallow the tablet whole with a full glass of water or milk. Do not crush, break, or chew it.
-
Ursomore-300 must strictly be taken orally with or immediately after food (typically in the evening or split across main meals) to optimize its emulsification and intestinal absorption metrics.
-
Gallstone dissolution and liver tracking adjustments are gradual processes; continuous daily compliance over 3 to 12 months is standard to achieve targeted results.
Safety & Precautions
-
Do not modify your dose or stop taking this medication suddenly. Halting therapy can stop the gallstone dissolution process, causing remaining particles to grow or aggregate again.
-
This medication is exclusively indicated for cholesterol-based stones; it is not effective against calcified, radiopaque pigment gallstones or a non-functioning gallbladder.
-
Avoid Antacids: Do not take aluminium-based antacids or bile acid-binding resins (like cholestyramine) at the same time as this medicine, as they bind to Ursodeoxycholic Acid and significantly reduce its absorption. Maintain a strict gap of at least 2 hours if required.
-
Periodic monitoring of liver function tests (LFT) and ultrasound scans is highly recommended during long-term care management.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.
-
Keep the tablets safely stored inside their original blister packaging configuration until the exact moment of consumption.
